Bharat Biotech’s Nasal Vaccine iNCOVACC To Cost Rs 800: Sources
The iNCOVACC is a recombinant replication-deficient adenovirus vectored vaccine with a pre-fusion stabilised spike protein.
- Latest
- Trending
The iNCOVACC is a recombinant replication-deficient adenovirus vectored vaccine with a pre-fusion stabilised spike protein.
Copyright © 2025 Frontier Media